Bryan H Goldstein, Doff B McElhinney, Matthew J Gillespie, Jamil A Aboulhosn, Daniel S Levi, Brian H Morray, Allison K Cabalka, Barry A Love, Jeffrey D Zampi, David T Balzer, Mark A Law, Mary D Schiff, Arvind Hoskoppal, Athar M Qureshi
BACKGROUND: Transcatheter pulmonary valve replacement (TPVR) with the self-expanding Harmony valve (Medtronic) is an emerging treatment for patients with native or surgically repaired right ventricular outflow tract (RVOT) pulmonary regurgitation (PR). Limited data are available since U.S. Food and Drug Administration approval in 2021. OBJECTIVES: In this study, the authors sought to evaluate the safety and short-term effectiveness of self-expanding TPVR in a real-world experience...
April 9, 2024: Journal of the American College of Cardiology